MergerLinks Daily Review

MergerLinks Daily Review

Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.

MNC raises offer for Vista Outdoor to $3bn. (Financial Sponsors)

Ingersoll Rand to acquire ILC Dover from New Mountain Capital for $2.325bn. (FS)

Novo Nordisk to acquire Cardior for €1.025bn.

Carlyle is among suitors for environmental consultant RSK. (FS)

TPG will halve China investments in new $5bn Asia fund. (FS)

You can access today’s complete newsletter here.

Scroll down for more…


MNC raises offer for Vista Outdoor to $3bn. (FS)

MNC Capital Inc. , an investment firm, raised its offer for Vista Outdoor Inc. , a sporting goods and outdoor products company, to $3bn.?

A transaction with MNC would not be subject to a financing contingency and would not be subject to CFIUS review. MNC has provided the details of its financing to Vista, as well as all other information that Vista requested in its March 4, 2024 letter.

Vista Outdoor is advised by Moelis & Company , 摩根士丹利 , Cravath, Swaine & Moore LLP (led by Aaron Gruber ) and Gibson Dunn . MNC Capital is advised by 博然思维集团 (led by Robert Christie ) and Gladstone Place Partners (led by Lauren Odell ).

Ingersoll Rand to acquire ILC Dover from New Mountain Capital for $2.325bn. (FS)

英格索兰 , a global provider of mission-critical flow creation and industrial solutions, agreed to acquire ILC Dover , a company specializing in the design and production of highly innovative solutions for biopharmaceutical, pharmaceutical, and medical device markets, from New Mountain Capital , a growth-oriented investment firm, for $2.325bn.

“This acquisition is the next phase of our long-term vision to expand into higher-growth end markets like life sciences. I am incredibly excited to partner with Corey and the outstanding team at ILC, whom we’ve admired for their innovative products and decades of experience in life sciences, to enhance our presence in key workflows and applications,” Vicente Reynal, Ingersoll Rand Chairman and CEO.

ILC Dover is advised by 高盛 , Jefferies and Simpson Thacher & Bartlett LLP . New Mountain Capital is advised by 高盛 , Jefferies , Simpson Thacher & Bartlett LLP and H/Advisors Abernathy (led by Dana Gorman ). Ingersoll Rand is advised by Kirkland & Ellis (led by Ravi Agarwal , Jennifer Perkins and Lee Blum ).

Novo Nordisk to acquire Cardior for €1.025bn.

诺和诺德 , a global healthcare company, agreed to acquire Cardior Pharmaceuticals , a company that discovers and develops therapies that target RNA as a means to prevent, repair and reverse diseases of the heart, for €1.025bn ($1.1bn).

“By welcoming Cardior as a part of Novo Nordisk, we will strengthen our pipeline of projects in cardiovascular disease where we already have ongoing programmes across all phases of clinical development. We have been impressed by the scientific work carried out by the Cardior team, especially on CDR132L, which has a distinctive mode of action and potential to become a first-in-class therapy designed to halt or partially reverse the course of disease for people living with heart failure,” Martin Holst Lange, Novo Nordisk Executive Vice President.

Cardior is advised by Trophic Communications (led by Stephanie May ).

Carlyle is among suitors for environmental consultant RSK. (FS)

凯雷投资集团 , one of the world's biggest private equity firms, is among a pack of suitors circling RSK Group , a British-based environmental consultancy, in a deal that would value it at well over £1bn ($1.25bn), SkyNews reported.

Carlyle is one of several parties in discussions with Alan Ryder, RSK's founder and chief executive, about a possible transaction. A deal could involve the outright purchase of a large minority stake in RSK, which employs more than 15k people and operates in 40 countries.


TPG will halve China investments in new $5bn Asia fund. (FS)

TPG will soon close its eighth Asia buyout fund at around $5bn, with the new portfolio set to slash its China allocation by more than half from prior regional funds, Bloomberg reported.

The investment firm plans to put about 10% of its Asia VIII pool in China, down from around 25% of invested capital in previous funds. TPG will allocate more than 80% in Australia, India and Southeast Asia — up from 70% in the predecessor fund. The rest will go to South Korea.

Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.

You can access today’s complete newsletter here.

要查看或添加评论,请登录

社区洞察

其他会员也浏览了